Carl Icahn no longer plans to solicit votes from Cigna shareholders against the health-insurer’s $54 billion deal to buy Express Scripts after two proxy-advisory firms recommended shareholders support the deal.
from WSJ.com: US Business https://ift.tt/2vJdpDl
via IFTTT
No comments:
Post a Comment